SAIF Partners Joins $345M Take-Private Proposal Of Sinovac Bitotech

NASDAQ-listed Chinese bio-pharmaceutical company Sinovac Biotech Ltd. says it has received a preliminary non-binding proposal from its chief executive and SAIF Partners to take the company private, according to a company announcement. The deal values the company at US$345 million based on total outstanding common shares of 55.8 million disclosed in its 2014 annual report, […]


Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Read the original article: China Money Network